Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Key Regulatory Elements of the TGFβ-LRRC15 Axis Predict Disease Progression and Immunotherapy Resistance Across Cancer Types.
Storey CM, Cheng M, Altai M, Park JE, Tran J, Lueong SS, Thorek D, Mao L, Zedan W, Yuen C, Ridley A, Trajovic-Arsic M, Herrmann K, Subuhdi SK, Siddiqui BA, Lückerath K, Siveke J, Damoiseaux R, Yang X, Ulmert D. Storey CM, et al. Among authors: ulmert d. bioRxiv [Preprint]. 2024 Nov 25:2024.11.22.624939. doi: 10.1101/2024.11.22.624939. bioRxiv. 2024. PMID: 39651139 Free PMC article. Preprint.
Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer.
Benabdallah N, Lu P, Abou DS, Zhang H, Ulmert D, Hobbs RF, Gay HA, Simons BW, Saeed MA, Rogers BE, Jha AK, Tai YC, Malone CD, Ippolito JE, Michalski J, Jennings JW, Baumann BC, Pachynski RK, Thorek DLJ. Benabdallah N, et al. Among authors: ulmert d. J Nucl Med. 2024 Feb 1;65(2):245-251. doi: 10.2967/jnumed.123.266571. J Nucl Med. 2024. PMID: 38124163 Free PMC article.
Evaluation of Candidate Theranostics for 227Th/89Zr Paired Radioimmunotherapy of Lymphoma.
Abou DS, Longtine M, Fears A, Benabdallah N, Unnerstall R, Johnston H, Shim K, Hasson A, Zhang H, Ulmert D, Mangin F, Ozen S, Raibaut L, Brandès S, Meyer M, Chambron JC, Tatum DS, Magda D, Wahl RL, Thorek DLJ. Abou DS, et al. Among authors: ulmert d. J Nucl Med. 2023 Jul;64(7):1062-1068. doi: 10.2967/jnumed.122.264979. Epub 2023 May 4. J Nucl Med. 2023. PMID: 37142300 Free PMC article.
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response.
Storey CM, Altai M, Bicak M, Veach DR, Lückerath K, Adrian G, McDevitt MR, Kalidindi T, Park JE, Herrmann K, Abou D, Zedan W, Peekhaus N, Klein RJ, Damoiseaux R, Larson SM, Lilja H, Thorek D, Ulmert D. Storey CM, et al. Among authors: ulmert d. Mol Cancer Res. 2023 Apr 1;21(4):307-315. doi: 10.1158/1541-7786.MCR-22-0736. Mol Cancer Res. 2023. PMID: 36608299 Free PMC article.
[18F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy response.
Zhang H, Abou D, Lu P, Hasson AM, Villmer A, Benabdallah N, Jiang W, Ulmert D, Carlin S, Rogers BE, Turtle NF, McDevitt MR, Baumann B, Simons BW, Dehdashti F, Zhou D, Thorek DLJ. Zhang H, et al. Among authors: ulmert d. Sci Rep. 2022 Jul 29;12(1):13034. doi: 10.1038/s41598-022-17460-0. Sci Rep. 2022. PMID: 35906379 Free PMC article.
Prostate cancer polygenic risk score and prediction of lethal prostate cancer.
Klein RJ, Vertosick E, Sjoberg D, Ulmert D, Rönn AC, Häggström C, Thysell E, Hallmans G, Dahlin A, Stattin P, Melander O, Vickers A, Lilja H. Klein RJ, et al. Among authors: ulmert d. NPJ Precis Oncol. 2022 Apr 8;6(1):25. doi: 10.1038/s41698-022-00266-8. NPJ Precis Oncol. 2022. PMID: 35396534 Free PMC article.
Improved Radium-223 Therapy with Combination Epithelial Sodium Channel Blockade.
Abou DS, Fears A, Summer L, Longtine M, Benabdallah N, Riddle RC, Ulmert D, Michalski J, Wahl RL, Chesner D, Doucet M, Zachos N, Simons B, Thorek DL. Abou DS, et al. Among authors: ulmert d. J Nucl Med. 2021 Apr 9;62(12):1751-8. doi: 10.2967/jnumed.121.261977. Online ahead of print. J Nucl Med. 2021. PMID: 33837069 Free PMC article.
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication.
Garcia G Jr, Sharma A, Ramaiah A, Sen C, Purkayastha A, Kohn DB, Parcells MS, Beck S, Kim H, Bakowski MA, Kirkpatrick MG, Riva L, Wolff KC, Han B, Yuen C, Ulmert D, Purbey PK, Scumpia P, Beutler N, Rogers TF, Chatterjee AK, Gabriel G, Bartenschlager R, Gomperts B, Svendsen CN, Betz UAK, Damoiseaux RD, Arumugaswami V. Garcia G Jr, et al. Among authors: ulmert d. Cell Rep. 2021 Apr 6;35(1):108940. doi: 10.1016/j.celrep.2021.108940. Epub 2021 Mar 18. Cell Rep. 2021. PMID: 33784499 Free PMC article.
PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates.
Veach DR, Storey CM, Lückerath K, Braun K, von Bodman C, Lamminmäki U, Kalidindi T, Strand SE, Strand J, Altai M, Damoiseaux R, Zanzonico P, Benabdallah N, Pankov D, Scher HI, Scardino P, Larson SM, Lilja H, McDevitt MR, Thorek DLJ, Ulmert D. Veach DR, et al. Among authors: ulmert d. Clin Cancer Res. 2021 Apr 1;27(7):2050-2060. doi: 10.1158/1078-0432.CCR-20-3614. Epub 2021 Jan 13. Clin Cancer Res. 2021. PMID: 33441295 Free PMC article.
75 results